These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 77414)

  • 1. Antibodies to synthetic polyribonucleotides in spouses of patients with inflammatory bowel disease.
    DeHoratius RJ; Strickland RG; Miller WC; Volpicelli NA; Gaeke RF; Kirsner JB; Williams RC
    Lancet; 1978 May; 1(8074):1116-9. PubMed ID: 77414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocytotoxic antibodies in patients with inflammatory bowel disease and their spouses--evidence for a transmissible agent.
    Strickland RG; Miller WC; Volpicelli NA; Gaeke RF; Wilson ID; Kirsner JB; Williams RC
    Clin Exp Immunol; 1977 Nov; 30(2):188-92. PubMed ID: 580077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rotavirus antibodies in Crohn's disease and ulcerative colitis.
    De Groote G; Desmyter J; Vantrappen G; Phillips CA
    Lancet; 1977 Jun; 1(8024):1263-4. PubMed ID: 68365
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibodies to polyadenylic acid in patients with myasthenia gravis.
    Fischbach M; Lindstrom J; Talal N
    Clin Exp Immunol; 1981 Jan; 43(1):73-9. PubMed ID: 7249396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphocytotoxic antibody in inflammatory bowel disease. A family study.
    Korsmeyer SJ; Williams RC; Wilson ID; Strickland RG
    N Engl J Med; 1975 Nov; 293(22):1117-20. PubMed ID: 1186774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of anti-lymphocyte antibodies in inflammatory bowel disease.
    Henderson CA; Greenlee L; Williams RC; Strickland RG
    Scand J Immunol; 1976; 5(6-7):837-44. PubMed ID: 790541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antineutrophil cytoplasmic antibodies in relatives of patients with inflammatory bowel disease.
    Papo M; Quer JC; Pastor RM; García-Pardo G; Prats E; Mirapeix E; Rodríguez R; Richart C
    Am J Gastroenterol; 1996 Aug; 91(8):1512-5. PubMed ID: 8759652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measles IgM immunoreactivity in patients with inflammatory bowel disease.
    Balzola FA; Khan K; Pera A; Bonino F; Pounder RE; Wakefield AJ
    Ital J Gastroenterol Hepatol; 1998 Aug; 30(4):378-82. PubMed ID: 9789132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum immunoglobulin M concentrations following bowel resection in chronic inflammatory bowel disease.
    Soltis RD; Wilson ID
    Gastroenterology; 1975 Oct; 69(4):885-92. PubMed ID: 1100468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polynucleotide antibodies in connective tissue disease: viral markers or disease mediators?
    Spencer-Green G; Kelley L; Adams LE; Donovan-Brand R; Hess EV
    J Lab Clin Med; 1986 Feb; 107(2):159-65. PubMed ID: 2418139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocytotoxic and RNA antibodies in inflammatory bowel disease: a comparative study in patients and their families.?
    Korsmeyer SJ; Williams RC; Wilson ID; Strickland RG
    Ann N Y Acad Sci; 1976; 278():574-85. PubMed ID: 1085596
    [No Abstract]   [Full Text] [Related]  

  • 12. Genetics of inflammatory bowel disease.
    Satsangi J; Jewell DP; Rosenberg WM; Bell JI
    Gut; 1994 May; 35(5):696-700. PubMed ID: 8200569
    [No Abstract]   [Full Text] [Related]  

  • 13. Significance of anergy to dinitrochlorobenzene (DNCB) in inflammatory bowel disease: family and postoperative studies.
    Meyers S; Sachar DB; Taub RN; Janowitz HD
    Gut; 1978 Apr; 19(4):249-52. PubMed ID: 648933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell immunoregulation in patients with inflammatory bowel disease. II. Enhanced suppressor T-cell activity in ulcerative colitis.
    Kramer JK; Depew WT; Szewczuk MR
    J Clin Lab Immunol; 1988 Jan; 25(1):19-27. PubMed ID: 2968458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased spontaneous secretion of rheumatoid factor by intestinal lamina propria mononuclear cells from Crohn's disease but not ulcerative colitis patients.
    MacDermott RP; Schreiber S; Nash GS; Koopman WJ
    Clin Exp Immunol; 1993 Apr; 92(1):152-7. PubMed ID: 8467559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P-ANCA in monozygotic twins with inflammatory bowel disease.
    Yang P; Järnerot G; Danielsson D; Tysk C; Lindberg E
    Gut; 1995 Jun; 36(6):887-90. PubMed ID: 7615278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoglobulin M memory B cell decrease in inflammatory bowel disease.
    Di Sabatino A; Carsetti R; Rosado MM; Ciccocioppo R; Cazzola P; Morera R; Tinozzi FP; Tinozzi S; Corazza GR
    Eur Rev Med Pharmacol Sci; 2004; 8(5):199-203. PubMed ID: 15638230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired immunity in patients with inflammatory bowel disease and hyposplenism: the response to intravenous phi X174.
    Ryan FP; Jones JV; Wright JK; Holdsworth CD
    Gut; 1981 Mar; 22(3):187-9. PubMed ID: 6453046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Autoantibodies in chronic inflammatory bowel diseases: more than an epiphenomenon?].
    Folwaczny C; Fricke H
    Z Gastroenterol; 1998 Jan; 36(1):105-8. PubMed ID: 9531690
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum lymphocytotoxic and lymphocytophilic antibody activity in inflammatory bowel disease.
    Korsmeyer S; Strickland RG; Wilson ID; Williams RC
    Gastroenterology; 1974 Oct; 67(4):578-83. PubMed ID: 4607065
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.